Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Severe Congenital Adrenal Hyperplasia Presenting as Bilateral Testicular Tumors and Azoospermia in the Third Decade of Life.

Sarfati J, Vatier C, Keller I, Guéchot J, Bellanné-Chantelot C, Christin-Maitre S.

J Endocr Soc. 2018 Jul 4;2(9):997-1000. doi: 10.1210/js.2018-00103. eCollection 2018 Sep 1.

2.

Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome.

Bellanné-Chantelot C, Schmaltz-Panneau B, Marty C, Fenneteau O, Callebaut I, Clauin S, Docet A, Damaj GL, Leblanc T, Pellier I, Stoven C, Souquere S, Antony-Debré I, Beaupain B, Aladjidi N, Barlogis V, Bauduer F, Bensaid P, Boespflug-Tanguy O, Berger C, Bertrand Y, Carausu L, Fieschi C, Galambrun C, Schmidt A, Journel H, Mazingue F, Nelken B, Quah TC, Oksenhendler E, Ouachée M, Pasquet M, Saada V, Suarez F, Pierron G, Vainchenker W, Plo I, Donadieu J.

Blood. 2018 Sep 20;132(12):1318-1331. doi: 10.1182/blood-2017-12-820308. Epub 2018 Jun 18.

PMID:
29914977
3.

The Common HNF1A Variant I27L Is a Modifier of Age at Diabetes Diagnosis in Individuals With HNF1A-MODY.

Locke JM, Saint-Martin C, Laver TW, Patel KA, Wood AR, Sharp SA, Ellard S, Bellanné-Chantelot C, Hattersley AT, Harries LW, Weedon MN.

Diabetes. 2018 Sep;67(9):1903-1907. doi: 10.2337/db18-0133. Epub 2018 Jun 12.

4.

Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients.

Donadieu J, Lamant M, Fieschi C, de Fontbrune FS, Caye A, Ouachee M, Beaupain B, Bustamante J, Poirel HA, Isidor B, Van Den Neste E, Neel A, Nimubona S, Toutain F, Barlogis V, Schleinitz N, Leblanc T, Rohrlich P, Suarez F, Ranta D, Chahla WA, Bruno B, Terriou L, Francois S, Lioure B, Ahle G, Bachelerie F, Preudhomme C, Delabesse E, Cave H, Bellanné-Chantelot C, Pasquet M; French GATA2 study group.

Haematologica. 2018 Aug;103(8):1278-1287. doi: 10.3324/haematol.2017.181909. Epub 2018 May 3.

5.

Hyperinsulinemic hypoglycemia without insulinoma: Think of activating glucokinase mutation.

Jannin A, Espiard S, Douillard C, Pasquier F, Bellanné-Chantelot C, Vantyghem MC.

Presse Med. 2018 Jun;47(6):595-597. doi: 10.1016/j.lpm.2018.02.015. Epub 2018 Mar 17. No abstract available.

PMID:
29555163
6.

New pathogenic mechanisms induced by germline erythropoietin receptor mutations in primary erythrocytosis.

Pasquier F, Marty C, Balligand T, Verdier F, Grosjean S, Gryshkova V, Raslova H, Constantinescu SN, Casadevall N, Vainchenker W, Bellanné-Chantelot C, Plo I.

Haematologica. 2018 Apr;103(4):575-586. doi: 10.3324/haematol.2017.176370. Epub 2017 Dec 21.

7.

Response to Comment on Dubois-Laforgue et al. Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (HNF1B) Molecular Defects. Diabetes Care 2017;40:1436-1443.

Dubois-Laforgue D, Cornu E, Saint-Martin C, Coste J, Bellanné-Chantelot C, Timsit J.

Diabetes Care. 2018 Jan;41(1):e8-e9. doi: 10.2337/dci17-0048. No abstract available.

PMID:
29263198
8.

Identification of MPL R102P Mutation in Hereditary Thrombocytosis.

Bellanné-Chantelot C, Mosca M, Marty C, Favier R, Vainchenker W, Plo I.

Front Endocrinol (Lausanne). 2017 Sep 20;8:235. doi: 10.3389/fendo.2017.00235. eCollection 2017.

9.

Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis.

Plo I, Bellanné-Chantelot C, Mosca M, Mazzi S, Marty C, Vainchenker W.

Front Endocrinol (Lausanne). 2017 Sep 12;8:234. doi: 10.3389/fendo.2017.00234. eCollection 2017. Review.

10.

Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history.

Donadieu J, Beaupain B, Fenneteau O, Bellanné-Chantelot C.

Br J Haematol. 2017 Nov;179(4):557-574. doi: 10.1111/bjh.14887. Epub 2017 Sep 6. Review.

PMID:
28875503
11.

How to differentiate congenital from noncongenital chronic neutropenia at the first medical examination? Proposal of score: A pilot study from the French Severe Chronic Neutropenia registry.

Bejjani N, Beaupain B, Bertrand Y, Bellanne-Chantelot C, Donadieu J.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26722. Epub 2017 Jul 20.

PMID:
28727239
12.

New somatic BRAF splicing mutation in Langerhans cell histiocytosis.

Héritier S, Hélias-Rodzewicz Z, Chakraborty R, Sengal AG, Bellanné-Chantelot C, Thomas C, Moreau A, Fraitag S, Allen CE, Donadieu J, Emile JF.

Mol Cancer. 2017 Jul 6;16(1):115. doi: 10.1186/s12943-017-0690-z.

13.

Lymphoid differentiation of hematopoietic stem cells requires efficient Cxcr4 desensitization.

Freitas C, Wittner M, Nguyen J, Rondeau V, Biajoux V, Aknin ML, Gaudin F, Beaussant-Cohen S, Bertrand Y, Bellanné-Chantelot C, Donadieu J, Bachelerie F, Espéli M, Dalloul A, Louache F, Balabanian K.

J Exp Med. 2017 Jul 3;214(7):2023-2040. doi: 10.1084/jem.20160806. Epub 2017 May 26.

14.

Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (HNF1B) Molecular Defects.

Dubois-Laforgue D, Cornu E, Saint-Martin C, Coste J, Bellanné-Chantelot C, Timsit J; Monogenic Diabetes Study Group of the Société Francophone du Diabète.

Diabetes Care. 2017 Nov;40(11):1436-1443. doi: 10.2337/dc16-2462. Epub 2017 Apr 18.

PMID:
28420700
15.

Intellectual disability in patients with MODY due to hepatocyte nuclear factor 1B (HNF1B) molecular defects.

Dubois-Laforgue D, Bellanné-Chantelot C, Charles P, Jacquette A, Larger E, Ciangura C, Saint-Martin C, Rastel C, Keren B, Timsit J; Monogenic Diabetes Study Group of the Société Francophone du Diabète (SFD).

Diabetes Metab. 2017 Feb;43(1):89-92. doi: 10.1016/j.diabet.2016.10.003. Epub 2016 Nov 10. No abstract available.

PMID:
27838256
16.

Application of whole-exome sequencing to unravel the molecular basis of undiagnosed syndromic congenital neutropenia with intellectual disability.

Gauthier-Vasserot A, Thauvin-Robinet C, Bruel AL, Duffourd Y, St-Onge J, Jouan T, Rivière JB, Heron D, Donadieu J, Bellanné-Chantelot C, Briandet C, Huet F, Kuentz P, Lehalle D, Duplomb-Jego L, Gautier E, Maystadt I, Pinson L, Amram D, El Chehadeh S, Melki J, Julia S, Faivre L, Thevenon J.

Am J Med Genet A. 2017 Jan;173(1):62-71. doi: 10.1002/ajmg.a.37969. Epub 2016 Sep 12.

PMID:
27615324
17.

ATG2B and GSKIP: 2 new genes predisposing to myeloid malignancies.

Plo I, Bellanné-Chantelot C, Vainchenker W.

Mol Cell Oncol. 2015 Oct 29;3(2):e1094564. doi: 10.1080/23723556.2015.1094564. eCollection 2016 Mar.

18.

Fetal anomalies associated with HNF1B mutations: report of 20 autopsy cases.

Duval H, Michel-Calemard L, Gonzales M, Loget P, Beneteau C, Buenerd A, Joubert M, Denis-Musquer M, Clemenson A, Chesnais AL, Blesson S, De Pinieux I, Delezoide AL, Bonyhay G, Bellanné-Chantelot C, Heidet L, Dupré F, Collardeau-Frachon S.

Prenat Diagn. 2016 Aug;36(8):744-51. doi: 10.1002/pd.4858. Epub 2016 Jul 6.

19.

Searching for Maturity-Onset Diabetes of the Young (MODY): When and What for?

Timsit J, Saint-Martin C, Dubois-Laforgue D, Bellanné-Chantelot C.

Can J Diabetes. 2016 Oct;40(5):455-461. doi: 10.1016/j.jcjd.2015.12.005. Epub 2016 Apr 18. Review.

PMID:
27103109
20.

Tubular proteinuria in patients with HNF1α mutations: HNF1α drives endocytosis in the proximal tubule.

Terryn S, Tanaka K, Lengelé JP, Olinger E, Dubois-Laforgue D, Garbay S, Kozyraki R, Van Der Smissen P, Christensen EI, Courtoy PJ, Bellanné-Chantelot C, Timsit J, Pontoglio M, Devuyst O.

Kidney Int. 2016 May;89(5):1075-1089. doi: 10.1016/j.kint.2016.01.027. Epub 2016 Mar 29.

PMID:
27083284
21.

Altered chemotactic response to CXCL12 in patients carrying GATA2 mutations.

Maciejewski-Duval A, Meuris F, Bignon A, Aknin ML, Balabanian K, Faivre L, Pasquet M, Barlogis V, Fieschi C, Bellanné-Chantelot C, Donadieu J, Schlecht-Louf G, Marin-Esteban V, Bachelerie F.

J Leukoc Biol. 2016 Jun;99(6):1065-76. doi: 10.1189/jlb.5MA0815-388R. Epub 2015 Dec 28.

PMID:
26710799
22.

Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients.

Cabagnols X, Favale F, Pasquier F, Messaoudi K, Defour JP, Ianotto JC, Marzac C, Le Couédic JP, Droin N, Chachoua I, Favier R, Diop MK, Ugo V, Casadevall N, Debili N, Raslova H, Bellanné-Chantelot C, Constantinescu SN, Bluteau O, Plo I, Vainchenker W.

Blood. 2016 Jan 21;127(3):333-42. doi: 10.1182/blood-2015-07-661983. Epub 2015 Oct 8.

23.

Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.

Saliba J, Saint-Martin C, Di Stefano A, Lenglet G, Marty C, Keren B, Pasquier F, Valle VD, Secardin L, Leroy G, Mahfoudhi E, Grosjean S, Droin N, Diop M, Dessen P, Charrier S, Palazzo A, Merlevede J, Meniane JC, Delaunay-Darivon C, Fuseau P, Isnard F, Casadevall N, Solary E, Debili N, Bernard OA, Raslova H, Najman A, Vainchenker W, Bellanné-Chantelot C, Plo I.

Nat Genet. 2015 Oct;47(10):1131-40. doi: 10.1038/ng.3380. Epub 2015 Aug 17.

PMID:
26280900
24.

Severe chronic primary neutropenia in adults: report on a series of 108 patients.

Sicre de Fontbrune F, Moignet A, Beaupain B, Suarez F, Galicier L, Socié G, Varet B, Coppo P, Michel M, Pautas C, Oksenhendler E, Lengline E, Terriou L, Moreau P, Chantepie S, Casadevall N, Michot JM, Gardembas M, Michallet M, Croisille L, Audrain M, Bellanné-Chantelot C, Donadieu J, Lamy T; French Severe Chronic Neutropenia Registry.

Blood. 2015 Oct 1;126(14):1643-50. doi: 10.1182/blood-2015-03-634493. Epub 2015 Aug 10.

25.

High-sensitivity C-reactive protein does not improve the differential diagnosis of HNF1A-MODY and familial young-onset type 2 diabetes: A grey zone analysis.

Bellanné-Chantelot C, Coste J, Ciangura C, Fonfrède M, Saint-Martin C, Bouché C, Sonnet E, Valéro R, Lévy DJ, Dubois-Laforgue D, Timsit J; Monogenic Diabetes Study Group of the Société Francophone du Diabète (SFD).

Diabetes Metab. 2016 Feb;42(1):33-7. doi: 10.1016/j.diabet.2015.02.001. Epub 2015 Mar 6.

PMID:
25753245
26.

Inadequate cortisol response to the tetracosactide (Synacthen®) test in non-classic congenital adrenal hyperplasia: an exception to the rule?

Stoupa A, González-Briceño L, Pinto G, Samara-Boustani D, Thalassinos C, Flechtner I, Beltrand J, Bidet M, Simon A, Piketty M, Laborde K, Morel Y, Bellanné-Chantelot C, Touraine P, Polak M.

Horm Res Paediatr. 2015;83(4):262-7. doi: 10.1159/000369901. Epub 2015 Feb 7.

PMID:
25677445
27.

NF1 single and multi-exons copy number variations in neurofibromatosis type 1.

Imbard A, Pasmant E, Sabbagh A, Luscan A, Soares M, Goussard P, Blanché H, Laurendeau I, Ferkal S, Vidaud M, Pinson S, Bellanne-Chantelot C, Vidaud D, Wolkenstein P; members of the NF France Network, Parfait B.

J Hum Genet. 2015 Apr;60(4):221-4. doi: 10.1038/jhg.2015.6. Epub 2015 Jan 29.

PMID:
25631097
28.

Strengths and limitations of using 18fluorine-fluorodihydroxyphenylalanine PET/CT for congenital hyperinsulinism.

Montravers F, Arnoux JB, Ribeiro MJ, Kerrou K, Nataf V, Galmiche L, Aigrain Y, Bellanné-Chantelot C, Saint-Martin C, Ohnona J, Balogova S, Huchet V, Michaud L, Talbot JN, de Lonlay P.

Expert Rev Endocrinol Metab. 2014 Sep;9(5):477-485. doi: 10.1586/17446651.2014.949240. Epub 2014 Aug 13.

PMID:
30736210
29.

JAGN1 deficiency causes aberrant myeloid cell homeostasis and congenital neutropenia.

Boztug K, Järvinen PM, Salzer E, Racek T, Mönch S, Garncarz W, Gertz EM, Schäffer AA, Antonopoulos A, Haslam SM, Schieck L, Puchałka J, Diestelhorst J, Appaswamy G, Lescoeur B, Giambruno R, Bigenzahn JW, Elling U, Pfeifer D, Conde CD, Albert MH, Welte K, Brandes G, Sherkat R, van der Werff Ten Bosch J, Rezaei N, Etzioni A, Bellanné-Chantelot C, Superti-Furga G, Penninger JM, Bennett KL, von Blume J, Dell A, Donadieu J, Klein C.

Nat Genet. 2014 Sep;46(9):1021-7. doi: 10.1038/ng.3069. Epub 2014 Aug 17.

30.

Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.

Saint-Martin C, Zhou Q, Martin GM, Vaury C, Leroy G, Arnoux JB, de Lonlay P, Shyng SL, Bellanné-Chantelot C.

Clin Genet. 2015 May;87(5):448-54. doi: 10.1111/cge.12428. Epub 2014 Jun 6.

31.

Pectus excavatum is part of the clinical spectrum of HNF1B MODY5.

Dubois-Laforgue D, Bellanné-Chantelot C, Subra JF, Timsit J.

Diabetes Care. 2014 Apr;37(4):e72-3. doi: 10.2337/dc13-2822. No abstract available.

PMID:
24652735
32.

Clinical utility gene card for: Maturity-onset diabetes of the young.

Colclough K, Saint-Martin C, Timsit J, Ellard S, Bellanné-Chantelot C.

Eur J Hum Genet. 2014 Sep;22(9). doi: 10.1038/ejhg.2014.14. Epub 2014 Feb 12. No abstract available.

33.

[WHIM syndrome: presumptive diagnosis based on myelokathexis on bone marrow smear].

Bock I, Dugué F, Loppinet E, Bellanné-Chantelot C, Bénet B.

Ann Biol Clin (Paris). 2014 Jan-Feb;72(1):111-9. doi: 10.1684/abc.2013.0928. French.

34.

Neurological findings and genetic alterations in patients with Kostmann syndrome and HAX1 mutations.

Roques G, Munzer M, Barthez MA, Beaufils S, Beaupain B, Flood T, Keren B, Bellanné-Chantelot C, Donadieu J.

Pediatr Blood Cancer. 2014 Jun;61(6):1041-8. doi: 10.1002/pbc.24964. Epub 2014 Jan 30. Review.

PMID:
24482108
35.

Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors.

Marty C, Saint-Martin C, Pecquet C, Grosjean S, Saliba J, Mouton C, Leroy E, Harutyunyan AS, Abgrall JF, Favier R, Toussaint A, Solary E, Kralovics R, Constantinescu SN, Najman A, Vainchenker W, Plo I, Bellanné-Chantelot C.

Blood. 2014 Feb 27;123(9):1372-83. doi: 10.1182/blood-2013-05-504555. Epub 2014 Jan 7.

36.

Cohen syndrome is associated with major glycosylation defects.

Duplomb L, Duvet S, Picot D, Jego G, El Chehadeh-Djebbar S, Marle N, Gigot N, Aral B, Carmignac V, Thevenon J, Lopez E, Rivière JB, Klein A, Philippe C, Droin N, Blair E, Girodon F, Donadieu J, Bellanné-Chantelot C, Delva L, Michalski JC, Solary E, Faivre L, Foulquier F, Thauvin-Robinet C.

Hum Mol Genet. 2014 May 1;23(9):2391-9. doi: 10.1093/hmg/ddt630. Epub 2013 Dec 13.

PMID:
24334764
37.

Unsolved issues related to human mitochondrial diseases.

Lombès A, Auré K, Bellanné-Chantelot C, Gilleron M, Jardel C.

Biochimie. 2014 May;100:171-6. doi: 10.1016/j.biochi.2013.08.012. Epub 2013 Aug 20. Review.

38.

NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience.

Sabbagh A, Pasmant E, Imbard A, Luscan A, Soares M, Blanché H, Laurendeau I, Ferkal S, Vidaud M, Pinson S, Bellanné-Chantelot C, Vidaud D, Parfait B, Wolkenstein P.

Hum Mutat. 2013 Nov;34(11):1510-8. doi: 10.1002/humu.22392. Epub 2013 Aug 26.

PMID:
23913538
39.

Epidemiology of congenital neutropenia.

Donadieu J, Beaupain B, Mahlaoui N, Bellanné-Chantelot C.

Hematol Oncol Clin North Am. 2013 Feb;27(1):1-17, vii. doi: 10.1016/j.hoc.2012.11.003. Review.

PMID:
23351985
40.

Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.

Colclough K, Bellanne-Chantelot C, Saint-Martin C, Flanagan SE, Ellard S.

Hum Mutat. 2013 May;34(5):669-85. doi: 10.1002/humu.22279. Epub 2013 Apr 2.

PMID:
23348805
41.

A dominant ABCC8-related hyperinsulinism: familial case report. Moreira et al. ABCC8-related hyperinsulinism.

Moreira MC, Piazzon FB, Carvalho MD, Quaio CR, Dutra AB, Ceccon ME, Della-Manna T, Tannuri U, Lee JH, Zerbini MC, Bellanne-Chantelot C, Lonlay P, Bertola DR, Kim CA.

Fetal Pediatr Pathol. 2013 Oct;32(5):384-6. doi: 10.3109/15513815.2012.754531. Epub 2013 Jan 10. No abstract available.

PMID:
23301914
42.

Could FISH on buccal smears become a new method of screening in children suspect of HNF1B anomaly?

Laffargue F, Bourthoumieu S, Bellanné-Chantelot C, Guigonis V, Yardin C.

Eur J Med Genet. 2013 Feb;56(2):93-7. doi: 10.1016/j.ejmg.2012.12.002. Epub 2012 Dec 20.

PMID:
23261960
43.

High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia.

Pasquet M, Bellanné-Chantelot C, Tavitian S, Prade N, Beaupain B, Larochelle O, Petit A, Rohrlich P, Ferrand C, Van Den Neste E, Poirel HA, Lamy T, Ouachée-Chardin M, Mansat-De Mas V, Corre J, Récher C, Plat G, Bachelerie F, Donadieu J, Delabesse E.

Blood. 2013 Jan 31;121(5):822-9. doi: 10.1182/blood-2012-08-447367. Epub 2012 Dec 6.

44.

Cardiomyopathies and congenital heart diseases in Shwachman-Diamond syndrome: a national survey.

Hauet Q, Beaupain B, Micheau M, Blayo M, Gandemer V, Gottrand F, Blin N, Fouyssac F, Lethor JP, Bellanné-Chantelot C, Bonnet D, Donadieu J.

Int J Cardiol. 2013 Aug 10;167(3):1048-50. doi: 10.1016/j.ijcard.2012.10.084. Epub 2012 Nov 17. No abstract available.

PMID:
23164595
45.

Incretin effect of glucagon-like peptide 1 receptor agonist is preserved in presence of ABCC8/SUR1 mutation in β-cell.

Bourron O, Chebbi F, Halbron M, Saint-Martin C, Bellanné-Chantelot C, Abed A, Charbit B, Magnan C, Lacorte JM, Hartemann A.

Diabetes Care. 2012 Nov;35(11):e76. doi: 10.2337/dc12-0535. No abstract available.

46.

Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications.

Malak S, Labopin M, Saint-Martin C, Bellanne-Chantelot C, Najman A; French Group of Familial Myeloproliferative Disorders.

Blood Cells Mol Dis. 2012 Oct 15-Dec 15;49(3-4):170-6. Epub 2012 Jul 19.

PMID:
22818858
47.

Hepatic hemangioendothelioma in an infant with severe congenital neutropenia.

Dinand V, Yadav SP, Bellanné-Chantelot C, Jain S, Bhargava M, Sachdeva A.

J Pediatr Hematol Oncol. 2012 May;34(4):298-300. doi: 10.1097/MPH.0b013e318249a4dc.

PMID:
22510773
48.

Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome.

Donadieu J, Fenneteau O, Beaupain B, Beaufils S, Bellanger F, Mahlaoui N, Lambilliotte A, Aladjidi N, Bertrand Y, Mialou V, Perot C, Michel G, Fouyssac F, Paillard C, Gandemer V, Boutard P, Schmitz J, Morali A, Leblanc T, Bellanné-Chantelot C; Associated investigators of the French Severe Chronic Neutropenia Registry*.

Haematologica. 2012 Sep;97(9):1312-9. Epub 2012 Apr 4.

49.

Maturity onset diabetes of the young: clinical characteristics and outcome after kidney and pancreas transplantation in MODY3 and RCAD patients: a single center experience.

Poitou C, Francois H, Bellanne-Chantelot C, Noel C, Jacquet A, Clauin S, Beaudreuil S, Damieri H, Hebibi H, Hammoudi Y, Benoit G, Charpentier B, Durrbach A.

Transpl Int. 2012 May;25(5):564-72. doi: 10.1111/j.1432-2277.2012.01458.x. Epub 2012 Mar 21.

50.

Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis.

Jaeger BN, Donadieu J, Cognet C, Bernat C, Ordoñez-Rueda D, Barlogis V, Mahlaoui N, Fenis A, Narni-Mancinelli E, Beaupain B, Bellanné-Chantelot C, Bajénoff M, Malissen B, Malissen M, Vivier E, Ugolini S.

J Exp Med. 2012 Mar 12;209(3):565-80. doi: 10.1084/jem.20111908. Epub 2012 Mar 5.

Supplemental Content

Loading ...
Support Center